We are live on
!
Find out more
Alnylam Pharmaceuticals
ALNY
ALNY
309 hedge funds and large institutions have $9B invested in Alnylam Pharmaceuticals in 2018 Q2 according to their latest regulatory filings, with 57 funds opening new positions, 122 increasing their positions, 80 reducing their positions, and 39 closing their positions.
New
Increased
Maintained
Reduced
Closed
88% more call options, than puts
Call options by funds: $106M | Put options by funds: $56.4M
53% more repeat investments, than reductions
Existing positions increased: 122 | Existing positions reduced: 80
46% more first-time investments, than exits
New positions opened: 57 | Existing positions closed: 39
6% more funds holding
Funds holding: 292 → 309 (+17)
0.44% less ownership
Funds ownership: 91.51% → 91.08% (-0.44%)
18% less capital invested
Capital invested by funds: $10.9B → $9B (-$1.92B)
25% less funds holding in top 10
Funds holding in top 10: 12 → 9 (-3)
Holders
309
Holders Change
+17
Holders Change %
+5.82%
% of All Funds
7.07%
Holding in Top 10
9
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-25%
% of All Funds
0.21%
New
57
Increased
122
Reduced
80
Closed
39
Calls
$106M
Puts
$56.4M
Net Calls
+$49.7M
Net Calls Change
+$46.2M
Top Buyers
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
+$216M |
| 2 |
ACA
Avoro Capital Advisors
New York
|
+$69.4M |
| 3 |
MC
Maverick Capital
Dallas,
Texas
|
+$67.6M |
| 4 |
JP Morgan Chase
New York
|
+$57.3M |
| 5 |
PA
Perceptive Advisors
New York
|
+$56.2M |
Top Sellers
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$730M |
| 2 |
BlackRock
New York
|
-$103M |
| 3 |
Janus Henderson Group
London,
United Kingdom
|
-$39.9M |
| 4 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$35.4M |
| 5 |
Adage Capital Partners
Boston,
Massachusetts
|
-$28.6M |
